Description
Semaglutide is a long-acting synthetic glucagon-like peptide-1 (GLP-1) receptor agonist with structural modifications that extend its half-life through albumin binding. As a research peptide, Semaglutide has been extensively studied for its effects on incretin signaling, glucose-dependent insulin release, and energy metabolism in laboratory research models.
Semaglutide is one of the most-studied GLP-1 analogs in metabolic research, with extensive literature characterizing its receptor pharmacology and signaling.
Research areas studied
- GLP-1 receptor pharmacology
- Glucose homeostasis in research models
- Incretin pathway and energy balance research
Quality assurance
- HPLC verified at 99%+ purity
- Certificate of Analysis (COA) available upon request
- Lyophilized in a research-grade facility under controlled conditions
For research purposes only. Not for human consumption, diagnostic, or therapeutic use.